CYCLOSERINE
CYCLOSERINES · PULMONARY TUBERCULOSIS ·+3
THE CHAO CENTER
Drug class
Cycloserines
The term "cycloserines" refers to cycloserine and closely related structural analogues rather than an officially designated, multi-agent pharmacological drug class, as cycloserine is the sole clinically established therapeutic entity. Read more about Cycloserines
3 drugs in this class 3 manufacturers
Drugs in Cycloserines
CYCLOSERINE
CYCLOSERINES · PULMONARY TUBERCULOSIS ·+3
MACLEODS PHARMA
CYCLOSERINE
CYCLOSERINES · PULMONARY TUBERCULOSIS ·+3
DR.REDDY'S LAB
Filter & compare in the drug finder →
Opens the drug finder with Cycloserines preselected. Add indication or manufacturer filters there.
The term "cycloserines" refers to cycloserine and closely related structural analogues rather than an officially designated, multi-agent pharmacological drug class, as cycloserine is the sole clinically established therapeutic entity.
Belonging functionally to the antimycobacterial or second-line antituberculosis agents, it is a cyclic structural analogue of D-alanine that inhibits bacterial cell-wall peptidoglycan synthesis by competitively blocking enzymes such as D-alanine racemase and D-alanyl-alanine synthetase.
Clinically, it is utilized as part of multidrug regimens primarily for treating active pulmonary and extrapulmonary tuberculosis—especially drug-resistant forms such as multidrug-resistant tuberculosis (MDR-TB)—and secondarily for select susceptible bacterial urinary tract infections when conventional therapies are ineffective or contraindicated.
-
nih.gov
The term "cycloserines" refers to cycloserine and closely related structural analogues rather than an officially designated, multi-agent pharmacological drug class, as cycloserine is the sole clinically established therapeutic entity Belonging functionally to the antimycobacterial or second-line antituberculosis agents, it is a cyclic structural analogue of D-alanine that inhibits bacterial cell-wall peptidoglycan synthesis by competitively blocking enzymes such as D-alanine racemase and D-alany...
-
drugs.com
The term "cycloserines" refers to cycloserine and closely related structural analogues rather than an officially designated, multi-agent pharmacological drug class, as cycloserine is the sole clinically established therapeutic entity
-
amerigoscientific.com
Belonging functionally to the antimycobacterial or second-line antituberculosis agents, it is a cyclic structural analogue of D-alanine that inhibits bacterial cell-wall peptidoglycan synthesis by competitively blocking enzymes such as D-alanine racemase and D-alanyl-alanine synthetase
-
wikipedia.org
Clinically, it is utilized as part of multidrug regimens primarily for treating active pulmonary and extrapulmonary tuberculosis—especially drug-resistant forms such as multidrug-resistant tuberculosis (MDR-TB)—and secondarily for select susceptible bacterial urinary tract infections when conventional therapies are ineffective or contraindicated
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.